Francisella FlmX broadly affects lipopolysaccharide modification and virulence

Chui-Yoke Chin1, Jinshi Zhao2, Anna C Llewellyn3

  • 1Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Yerkes National Primate Research Center, Emory University School of Medicine, Atlanta, GA 30329, USA; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30329, USA.

Cell Reports
|June 16, 2021
PubMed
Summary

A newly discovered protein, FlmX, unexpectedly connects key pathways for constructing bacterial lipopolysaccharide (LPS). Its absence severely weakens Francisella tularensis, highlighting FlmX as a potential drug target.